Insurance

Debunking Cancer Insurance Myths – Here Are 4 Things You Must Know

Don’t let these myths and misconceptions about cancer insurance deter you from getting protected against the top critical illness in Singapore.1 Updated on 26 January 2022.

  • Phuan Wei Ning
  • |
  • Published on 28 Sep 2021

What is your biggest deterrence to getting cancer insurance? Is it the cost, the dread of a tedious application process or simply the lack of knowledge for such plans? With a 1 in 4 chance of developing cancer in your lifetime, cancer protection is an issue that should be addressed.2 In this article, we highlight some of the common myths and misconceptions that you may have about cancer insurance and reveal the truth behind these claims.


Myth 1: Having both cancer insurance and MediShield Life will result in overlapping coverage

While MediShield Life covers for hospitalisation and specified cancer treatments, the intention of the coverage between the two is different.

MediShield Life operates on a reimbursement basis which means that you will only be reimbursed for the amount spent on eligible treatments. For example, if you were to spend $3,000 on eligible cancer drug treatments, you will only be reimbursed $3,000 from MediShield Life. While this helps to take care of the costs incurred from your cancer treatment, this will not help you with the cost of your long-term care or daily living expenses.

Cancer plans on the other hand, operates on a lump sum pay-out basis. While different plans will have varying conditions for pay-outs, plans such as FWD Cancer will provide a lump sum pay-out upon the diagnosis of cancer. This means that if you are insured for $100,000, you will receive this full $100,000 as pay-out from FWD upon the diagnosis of cancer. There are also no restrictions on how this pay-out is to be used. This allows you the flexibility to use it as income replacement, for your daily living expenses while you recover, or for any long-term care costs that you may incur.


**Exclusive promotion**

Enjoy 28% discount and a chance to win $88 red packets in FWD's lucky draw for your FWD Term Life Plus when you purchase with promo code "IFAST". Lucky draw T&Cs apply.


Check my price >


Myth 2: I do not need cancer insurance if I am not earning an income

Cancer plans are typically recommended to be used for income replacement, with the pay-out allowing you to focus on your recovery without having to worry about your finances. However, individuals who are not earning an income (e.g. stay-home parent(s) or children) will also benefit from cancer insurance. This is because apart from serving as income replacement, pay-outs from a cancer plan can also help to cover other "unseen" expenses.

For example, if a child is diagnosed with cancer, the parent may wish to take time off to care for the child. This may affect the parent's income during the child’s recovery period. However, if the child has a cancer insurance plan, the child will be eligible for a pay-out regardless of whether he/she is earning an income. This pay-out can then serve as the parent's income replacement, helping to pay for their daily living expenses and thus allowing the parent to care for the child without having to worry about their finances.

Likewise, while a stay-home parent does not earn an income, there may be unseen "costs" incurred if he/she is ill and unable to handle the usual duties such as child care or cleaning. In this scenario, the pay-out from a cancer plan can then be used to hire a helper to care for the child or to clean the house.

(See "I have DPS, do I still need Term plans?")


Myth 3: Cancer plans are expensive

Contrary to popular belief, critical illness coverage is not necessarily expensive. From just $12 a month^ (before discounts) for $100,000 coverage, the premiums for Cancer plans tend to be lower than other early critical illness insurance. This thus makes cancer plans suitable if you are looking for an affordable plan to kick-start your critical illness coverage.

Alternatively, if you are concerned with being diagnosed with cancer and would like additional coverage, a cancer plan is also a good way to supplement any existing coverage.

Age
Coverage amount
Monthly premiums
Male (non-smoker)
Female (non-smoker)
20
$100,000
$12
$20
30
$100,000
$12
$20
40
$100,000
$21
$43
50
$100,000
$49
$66
60
$100,000
$98
$81

Premiums shown are before discounts and are rounded down to the nearest whole number. Information is accurate as of 13 October 2021 with changes subjected to the insurer’s discretion.


Myth 4: I can wait for the right time to buy cancer insurance

There is no “right” time to buy cancer plans as cancer can occur at any age.3 Instead, get cancer plans if you are worried about getting cancer or would like a peace of mind knowing that you are financially covered in the event of a cancer diagnosis.

Getting cancer insurance coverage is simple as many plans do not require you to go through a medical check-up. Instead, all you have to do is to just answer a few health declaration questions to see if you are eligible for cover. Coverage may also be given even if you have pre-existing conditions that are not related to cancer.

Lastly, cancer plans are fuss-free to purchase and can easily be bought directly online. This means that you do not have to meet an adviser to purchase with the entire process digitised and simple to understand.


Cancer insurance available on FSMOne


Name of plan
Allianz Cancer Protect
FWD Cancer Insurance
CancerCare Plus
NTUC Cancer Protect
TM Protect Cancer
Entry age
Age 18 to 65 Age Last Birthday (ALB)
Age 18 to 65 Age Last Birthday (ALB)
Age 20 to 64 Age Last Birthday (ALB)
Age 30 to 64 Age Last Birthday (ALB)
Age 29 to 64 Age Last Birthday (ALB)
Coverage levels available
$50,000, $75,000 or $100,000
$50,000, $100,000 or $200,000
$100,000
$50,000, $80,000 or $100,000
$50,000 to $150,000. Coverage can be increased in increments of $1,000
Medical underwriting
Not required. Just answer 2 to 3 underwriting questions.
Not required. Just answer 1 health declaration. Cover may be given even with pre-existing non-cancer related medical conditions.
Not required. Just answer 3 health declaration questions.
May require medical check-up if deemed necessary.
Just answer 7 health-related questions.
Pay-outs given in...
Pay-outs are staggered based on whether condition is invasive or non-invasive.
Full pay-out given upon diagnosis.
Pay-outs staggered based on early or advanced stage cancer.
Pay-outs staggered based on early or advanced stage cancer.
Pay-outs staggered based on early or advanced stage cancer.
Annual premiums* (after discounts)
$266.92
$105.56
$94.16
$207.70
$156
Ongoing promotions
-
28% off + lucky draw chance with promo code "IFAST". T&Cs apply.

-
-
-

*Profile: Age 30, non-smoker male for $100,000 coverage.

Information shown is accurate as of 26 January 2022 with changes subjected to the insurer’s discretion.


Let FSMOne help you with your insurance planning

Over 10,300 users trust FSMOne with their insurance planning.

Live better, safer. Get a free review from our advisers today!

Get Started >


Click here to find out how much protection you need


Available Products on FSMOne Insurance

Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)


from AIG, Allianz, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Manulife, NTUC Income, QBE, Sompo and Tokio Marine Life Insurance


*Please check with our advisory team if the product you want is available on FSMOne Insurance


Interested to learn more? Check out these articles:

How will changes to MediShield Life’s cancer coverage affect me?

Are annuities good for retirement planning?

Is maternity insurance a must-have for all expecting mothers?

Cheap Cancer Insurance Singapore 2021

All you need to know about the new integrated shield riders


^Profile: Age 30, non-smoker male for $100,000 cancer coverage.


----

1 Source: https://www.genre.com/knowledge/publications/ri15-4-droste-xiang-en.html

2 https://www.singaporecancersociety.org.sg/learn-about-cancer/cancer-basics/common-types-of-cancer-in-singapore.html

3 Source: https://www.nrdo.gov.sg/docs/librariesprovider3/default-document-library/scr-annual-report-2018.pdf?sfvrsn=bcf56c25_0

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.


Ways to Invest with FSM Global
Why FSM Global
Don't have an account with us?
Open an account here
Need Financial Advice?
Make an appointment
Related Articles More

We use cookies If you close this message or continue to use this site, you will consent to the use of Cookies, unless you choose to disable them. Click on our Privacy Policy to understand more.